TRIM29 and cervical carcinoma: In this study, we demonstrate that TRIM29 is overexpressed in cervical cancer and correlated with PLNM, advanced FIGO stage, postoperative recurrence and poor survival of patients, suggesting TRIM29 plays an oncogenic role in cervical cancer.